The global life sciences landscape has evolved into an interconnected ecosystem where the security of a single pharmaceutical entity is inextricably linked to the cyber resilience of its smallest third-party vendor. As digital transformation continues to integrate advanced technologies like artificial intelligence and decentralized clinical trials
Modern cybersecurity defenders are currently locked in a relentless race against sophisticated attackers who leverage automated tools to identify and exploit vulnerabilities within seconds of their discovery. This high-stakes environment has compelled major technology providers to rethink their approach to software integrity and vulnerability

Cybersecurity defenses have traditionally relied heavily on recognizable indicators: known malware signatures, suspicious files, malicious domains, and other artifacts that can be identified and blocked. Increasingly, however, threat actors are combining legitimate system utilities, obfuscated scripts, social engineering, and generative AI to make attacks more difficult to identify through any

The Protocol That Can Make Email Interception Obsolete The email your CFO sent this morning traveled through at least half a dozen servers before reaching its destination. At any one of those handoffs, without proper encryption enforcement, an attacker could have read, copied, or altered its contents. MTA-STS exists to close that gap permanently. For years, email security has mainly focused on

The inherent inconsistency of Large Language Models means that a single refusal of a harmful prompt provides a false sense of security regarding total system safety. In the current landscape of 2026, enterprises are integrating sophisticated AI into every facet of operations, yet the protocols designed to protect these systems remain dangerously manual. Recent security benchmarks reveal that multi-turn jailbreak attacks—where an adversary uses a series of deceptive prompts to bypass safety filters—succeed at a staggering rate of 93% in corporate env
